Skip to main content
. 2018 Aug 31;10(8):e3237. doi: 10.7759/cureus.3237

Table 2. Summary of Lesion Characteristics and Radiotherapy Planning.

GTV: gross tumor volume; LC: local control; OS: overall survival; KPS: Karnofsky performance status; VAS: visual analogue scale; cc: cubic centimeters

Variable  
Median GTV (cc) (range) 34.09  (1.00 - 258.12)
Lesion Location    
Nasopharynx 15 patients (33.33%)
Gum, floor of mouth, other mouth 5 patients (11.11%)
Tongue 9 patients (20.00%)
Oropharynx 10 patients (22.22%)
Pharynx/location not specified 5 patients (11.11%)
Hypopharynx 1 patient (2.22%)
Median prescribed dose (range) 30 Gy (20 Gy - 42.5 Gy)
Median time to locoregional failure (LRF) (months) (range) 6.07 (1.5 - 59.43)
Median OS (months) (range)  9.23 (0.7 - 59.43)
Median KPS after treatment (range) 80% (10% - 100%)
Patients with rise in KPS 3 patients (14.29%)
Patients with no change in KPS 17 patients (80.95%)
Patients with decline in KPS 1 patient (4.76%)
Median VAS pain score after treatment (range) 0 (0 - 10)
Patients with rise in VAS pain score 3 patients (13.04%)
Patients with no change in VAS pain score 12 patients (52.17%)
Patients with decline in VAS pain score 8 patients (34.78%)